Healthcare -
Biotechnology - NASDAQ - US
$ 493.756
-0.384 %
$ 52.4 B
Market Cap
12.27
P/E
REGN - INTEREST INCOME & EXPENSE
Interest Income & Expense REGN - Regeneron Pharmaceuticals, Inc.
55.2 M
LAST VALUE
-3.60%
2 YEAR CAGR
12.82%
5 YEAR CAGR
3.98%
10 YEAR CAGR